Effect of Telitacicept on Antibody Titers in Primary APS Patients

Clinical trial NCT06315530 · COMPLETED

Trial details

NCT number: NCT06315530
Sponsor: Ruijin Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Antiphospholipid Syndrome (APS)

Start date: 2023-12-01
Primary completion: 2025-04-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.